Neuroscientific Biopharmaceuticals Ltd has released a press release.
Trading Halt
Earlier from Neuroscientific Biopharmaceuticals
- Fourth Patient Commences StemSmart MSC Treatment
- 2025 Annual Report & Appendix 4E
- Previous StemSmart Studies Support Renal Transplantation
- Experienced Cell Therapy Executive Appointed CEO